Second Sight to Discuss 2015 Third Quarter Financial Results on October 29, 2015 Conference Call

SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, will release its 2015 third quarter results on Thursday, October 29, 2015, after the close of the U.S. financial markets.

Dr. Robert Greenberg, Chairman, Will McGuire, President and Chief Executive Officer, and Tom Miller, Chief Financial Officer, will host a conference call to discuss the results as follows:

Date       Thursday, October 29, 2015
Time 4:30 p.m. EDT
Toll free (U.S.)

(800) 926-9871

International (415) 226-5355
Webcast (live and replay)

www.secondsight.com under the ‘Investor Relations’ section.

A replay of the conference call will be available for two weeks after the call's completion by dialing (800) 633-8284 (U.S.) or (402) 977-9140 (International). The conference ID for the replay is 21780255. The archived webcast will be available for 30 days via the aforementioned URL.

About Second Sight

Second Sight's mission is to develop, manufacture and market innovative implantable visual prosthetics to enable blind individuals to achieve greater independence. Second Sight has developed and manufactures the Argus® II Retinal Prosthesis System. Enrollment is underway in a trial to test the safety and utility of the Argus II in individuals with Dry Age-Related Macular Degeneration. Second Sight is also developing the Orion™ I Visual Cortical Prosthesis to restore some vision to individuals who are blind due to causes other than preventable or treatable conditions. U.S. Headquarters are in Sylmar, CA, and European Headquarters are in Lausanne, Switzerland. For more information, visit www.secondsight.com.

Investor Relations:
Retail Investors:
MZ North America
Matt Hayden, Chairman
949-259-4896
matt.hayden@mzgroup.us
or
Institutional Investors:
In-Site Communications, Inc.
Lisa Wilson, President
212-452-2793
lwilson@insitecony.com

Source: Second Sight Medical Products, Inc.